New Glaucoma Treatment Effective in Trial

Wednesday, 25 Jun 2014 12:15 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink

Drug developer Aerie Pharmaceuticals Inc said its single-drop eye treatment was shown to be superior to each of its two components in a mid-stage trial, sending its shares up by about 24 percent in premarket trading.
The drug, Roclatan, combines Aerie's other experimental glaucoma drug Rhopressa with the approved latanoprost.
Patients treated with the drug experienced a significant reduction in fluid pressure inside the eye, compared with those treated with either latanoprost or Rhopressa.
Glaucoma is a condition in which increased eye pressure could damage the optic nerve and lead to blindness, if left untreated.
Aerie Pharma said it would immediately start preparing for Roclatan's late-stage trial.
It is also preparing to start a late-stage trial for Rhopressa early in the third quarter.
 

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Dry-Roasted Peanuts More Likely to Trigger Allergy

Monday, 22 Sep 2014 16:46 PM

The process of dry-roasting peanuts - and not the nuts themselves - may account for allergic reactions in so many Americ . . .

Chris Christie Reveals He's Lost 85 Pounds Since Weight Loss Surgery

Monday, 22 Sep 2014 16:42 PM

Gov. Chris Christie has not publicly revealed how much weight he's lost since undergoing bariatric surgery last year. Bu . . .

New App Is Game-Changer for Blind

Monday, 22 Sep 2014 16:34 PM

A new app that allows blind people to listen to an audio readback of printed text is receiving rave reviews after its fi . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved